Vilma Ruperto

1.1k total citations · 1 hit paper
19 papers, 863 citations indexed

About

Vilma Ruperto is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Organic Chemistry. According to data from OpenAlex, Vilma Ruperto has authored 19 papers receiving a total of 863 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 15 papers in Cellular and Molecular Neuroscience and 2 papers in Organic Chemistry. Recurrent topics in Vilma Ruperto's work include Receptor Mechanisms and Signaling (19 papers), Neuropeptides and Animal Physiology (8 papers) and Neuroscience and Neuropharmacology Research (7 papers). Vilma Ruperto is often cited by papers focused on Receptor Mechanisms and Signaling (19 papers), Neuropeptides and Animal Physiology (8 papers) and Neuroscience and Neuropharmacology Research (7 papers). Vilma Ruperto collaborates with scholars based in United States and United Kingdom. Vilma Ruperto's co-authors include Gordon Crosby, William Billard, Allen Barnett, Louis C. Iorio, Samuel Chackalamannil, Ruth A. Duffy, Jean E. Lachowicz, Herbert Binch, Yuguang Wang and William J. Greenlee and has published in prestigious journals such as Journal of Medicinal Chemistry, Life Sciences and Psychopharmacology.

In The Last Decade

Vilma Ruperto

19 papers receiving 776 citations

Hit Papers

Characterization of the binding of 3H-SCH 23390, a select... 1984 2026 1998 2012 1984 100 200 300 400 500

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Vilma Ruperto United States 11 500 498 215 57 51 19 863
Bertrand L. Chenard United States 15 256 0.5× 257 0.5× 235 1.1× 67 1.2× 32 0.6× 28 668
Linda L. Coughenour United States 18 394 0.8× 352 0.7× 267 1.2× 73 1.3× 23 0.5× 29 806
Jean‐Marc Kamenka France 16 635 1.3× 792 1.6× 93 0.4× 62 1.1× 58 1.1× 41 1.1k
Peter J. Lovell United Kingdom 16 564 1.1× 511 1.0× 493 2.3× 75 1.3× 25 0.5× 23 1.2k
Helmut A. Ensinger Germany 13 337 0.7× 255 0.5× 95 0.4× 82 1.4× 89 1.7× 21 641
Neil R. Curtis United Kingdom 20 682 1.4× 611 1.2× 441 2.1× 86 1.5× 26 0.5× 31 1.2k
Frances Emms United Kingdom 15 619 1.2× 555 1.1× 270 1.3× 39 0.7× 52 1.0× 18 975
Kazuyuki Tomisawa Japan 15 317 0.6× 271 0.5× 130 0.6× 42 0.7× 16 0.3× 51 846
Steven Z. Whetzel United States 13 433 0.9× 443 0.9× 227 1.1× 53 0.9× 56 1.1× 20 841
Virginia L. Lucaites United States 19 491 1.0× 577 1.2× 217 1.0× 77 1.4× 14 0.3× 24 997

Countries citing papers authored by Vilma Ruperto

Since Specialization
Citations

This map shows the geographic impact of Vilma Ruperto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vilma Ruperto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vilma Ruperto more than expected).

Fields of papers citing papers by Vilma Ruperto

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vilma Ruperto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vilma Ruperto. The network helps show where Vilma Ruperto may publish in the future.

Co-authorship network of co-authors of Vilma Ruperto

This figure shows the co-authorship network connecting the top 25 collaborators of Vilma Ruperto. A scholar is included among the top collaborators of Vilma Ruperto based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vilma Ruperto. Vilma Ruperto is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Chackalamannil, Samuel, et al.. (2004). Himbacine analogs as muscarinic receptor antagonists––effects of tether and heterocyclic variations. Bioorganic & Medicinal Chemistry Letters. 14(15). 3967–3970. 9 indexed citations
2.
Palani, Anandan, Sundeep Dugar, John W. Clader, et al.. (2004). Isopropyl amide derivatives of potent and selective muscarinic M2 receptor antagonists. Bioorganic & Medicinal Chemistry Letters. 14(7). 1791–1794. 3 indexed citations
3.
McCombie, Stuart W., Jayaram R. Tagat, Dennis V. Nazareno, et al.. (2002). Synthesis and structure–Activity relationships of M2-Selective muscarinic receptor ligands in the 1-[4-(4-Arylsulfonyl)-phenylmethyl]-4-(4-piperidinyl)-piperazine family. Bioorganic & Medicinal Chemistry Letters. 12(5). 795–798. 8 indexed citations
4.
Wang, Yuguang, Samuel Chackalamannil, Zhiyong Hu, et al.. (2002). Sulfide analogues as potent and selective M2 muscarinic receptor antagonists. Bioorganic & Medicinal Chemistry Letters. 12(7). 1087–1091. 6 indexed citations
5.
Vice, Susan F., Samuel Chackalamannil, Stuart W. McCombie, et al.. (2002). Enhancement of pharmacokinetic properties and in vivo efficacy of benzylidene ketal M2 muscarinic receptor antagonists via benzamide modification. Bioorganic & Medicinal Chemistry Letters. 12(23). 3479–3482. 5 indexed citations
6.
Kozlowski, Joseph A., Guowei Zhou, Jayaram R. Tagat, et al.. (2002). Substituted 2-(R)-Methyl piperazines as muscarinic M2 selective ligands. Bioorganic & Medicinal Chemistry Letters. 12(5). 791–794. 15 indexed citations
7.
Wang, Yuguang, Samuel Chackalamannil, Zhiyong Hu, et al.. (2002). Improving the Oral Efficacy of CNS Drug Candidates:  Discovery of Highly Orally Efficacious Piperidinyl Piperidine M2 Muscarinic Receptor Antagonists. Journal of Medicinal Chemistry. 45(25). 5415–5418. 9 indexed citations
8.
Lachowicz, Jean E., Ruth A. Duffy, Vilma Ruperto, et al.. (2001). Facilitation of acetylcholine release and improvement in cognition by a selective M2 muscarinic antagonist, SCH 72788. Life Sciences. 68(22-23). 2585–2592. 32 indexed citations
9.
Wang, Yuguang, Samuel Chackalamannil, William J. Greenlee, et al.. (2001). Design and synthesis of ether analogues as potent and selective M2 muscarinic receptor antagonists. Bioorganic & Medicinal Chemistry Letters. 11(7). 891–894. 45 indexed citations
10.
Billard, William, Herbert Binch, Gordon Crosby, et al.. (2000). Diphenylsulfone muscarinic antagonists: piperidine derivatives with high m2 selectivity and improved potency. Bioorganic & Medicinal Chemistry Letters. 10(19). 2209–2212. 13 indexed citations
11.
Wang, Yuguang, Samuel Chackalamannil, Zhiyong Hu, et al.. (2000). Design and synthesis of piperidinyl piperidine analogues as potent and selective M2 muscarinic receptor antagonists. Bioorganic & Medicinal Chemistry Letters. 10(20). 2247–2250. 85 indexed citations
12.
Kozlowski, Joseph A., Derek Lowe, Henry Guzik, et al.. (2000). Diphenyl sulfoxides as selective antagonists of the muscarinic M2 receptor. Bioorganic & Medicinal Chemistry Letters. 10(20). 2255–2257. 10 indexed citations
13.
Chackalamannil, Samuel, Sundeep Dugar, William Billard, et al.. (2000). Benzylidene ketal derivatives as M2 muscarinic receptor antagonists. Bioorganic & Medicinal Chemistry Letters. 10(24). 2727–2730. 8 indexed citations
14.
Lachowicz, Jean E., Derek Lowe, Ruth A. Duffy, et al.. (1999). SCH 57790: A novel M2 receptor selective antagonist. Life Sciences. 64(6-7). 535–539. 19 indexed citations
15.
Doller, Darı́o, et al.. (1999). Design, synthesis, and structure-activity relationship studies of himbacine derived muscarinic receptor antagonists. Bioorganic & Medicinal Chemistry Letters. 9(6). 901–906. 48 indexed citations
16.
Tedford, Clark E., Vicki L. Coffin, Vilma Ruperto, et al.. (1993). Determination of plasma and brain concentrations of SCH 39166 and their correlation to conditioned avoidance behavior in rats. Psychopharmacology. 113(2). 199–204. 10 indexed citations
17.
Tedford, Clark E., et al.. (1992). SCH 39166, a novel dopamine D1 receptor antagonist: In vitro investigation of its glucuronidation and potential species differences. Drug Development Research. 26(4). 389–403. 9 indexed citations
18.
Tedford, Clark E., Vilma Ruperto, & A Barnett. (1991). Characterization of a rat liver glucuronosyltransferase that glucuronidates the selective D1 antagonist, SCH 23390, and other benzazepines.. Drug Metabolism and Disposition. 19(6). 1152–1159. 12 indexed citations
19.
Billard, William, Vilma Ruperto, Gordon Crosby, Louis C. Iorio, & Allen Barnett. (1984). Characterization of the binding of 3H-SCH 23390, a selective D-1 receptor antagonist ligand, in rat striatum. Life Sciences. 35(18). 1885–1893. 517 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026